NEU neuren pharmaceuticals limited

Ann: Neuren submits IND & first patients complete Phase 2 trials, page-15

  1. 2,981 Posts.
    lightbulb Created with Sketch. 643
    I know that on the odd occasion that NEU has missed some timelines (by not very much however), but essentially this is a company that has been brilliantly managed and had delivered on virtually every promise they've made in the 10+ years I've been invested.

    NEU couldn't be better set up than to be in a position where multiple propositions are going to be put to them in the next 12 months.

    I suspect that I'm one of many extremely satisfied and excited investors.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.